English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, December 1, 2020
BioVaxys Provides Viral Vaccine Platform Program Update
Monday, November 30, 2020
BioVaxys Provides Viral Vaccine Platform Program Update
Wednesday, November 11, 2020
BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine
Monday, November 2, 2020
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity

Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575